Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015839
Chunk: 287

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 287
---
 Raza Bokhari                                      |
|                     | Name: Dr. Raza Bokhari                                
 Title: Executive Chairman and Chief Executive Officer |

<div align='center'>II-9

POWERS OF ATTORNEY</div>

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Dr. Raza Bokhari,Carolyn Bonner, Maryann Adesso or James Quinlan, or any of them, with full power to act alone, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any or all amendments or supplements to this registration statement, whether pre-effective or post-effective, including any subsequent registration statement for the same offering which may be filed under Rule 462(b) under the Securities Act and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the SEC, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing necessary to be done, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his substitute, may lawfully do or cause to be done by virtue hereof.

This Power of Attorney may be executed in multiple counterparts, each of which shall be deemed an original, but which taken together shallconstituteone instrument.

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated below.

| Signature                   
 /s/ Raza Bokhari            |     | Title                                                          
 Executive Chairman and Chief Executive Officer                 
 (Principal Executive Officer)                                  |     | Date               
 September 29, 2025 |
|:----------------------------|:----|:---------------------------------------------------------------|:----|:-------------------|
| Dr. Raza Bokhari            |     |                                                                |     |                    |
| /s/ Carolyn Bonner          |     | President and Acting Chief Financial Officer                   
 (Principal Financial Officer and Principal Accounting Officer) |     | September 29, 2025 |
| Carolyn Bonner              |     |                                                                |     |                    |
| /s/ Larry Kaiser            |     | Director                                                       |     | September 29, 2025 |
| Dr. Larry Kaiser